Inter-hospital COVID ECMO air transportation.
Ismael A Salas de ArmasBindu H AkkantiLisa JanowiakIgor BanjacKha DinhRahat HussainRodolfo CabreraTony HerreraDamon SangerMehmet H AkayJayeshkumar PatelManish K PatelSachin KumarMarwan JumeanBiswajit KarIgor D GregoricPublished in: Perfusion (2020)
The Coronavirus Disease 2019 (COVID-19) pandemic has required rapid and effective protocol adjustments at every level of healthcare. The use of extracorporeal membrane oxygenation (ECMO) is pivotal to COVID-19 treatment in cases of refractory hypoxemic hypercapnic respiratory failure. As such, our large, metropolitan air ambulance system in conjunction with our experts in advanced cardiopulmonary therapies modified protocols to assist peripheral hospitals in evaluation, cannulation and initiation of ECMO for rescue and air transportation of patients with COVID-19 to our quaternary center. The detailed protocol is described alongside initial data of its use. To date, 14 patients have been placed on ECMO support at an outside facility and successfully transported via helicopter to our hub hospital using this protocol.
Keyphrases
- chronic kidney disease
- respiratory failure
- extracorporeal membrane oxygenation
- end stage renal disease
- coronavirus disease
- healthcare
- acute respiratory distress syndrome
- randomized controlled trial
- sars cov
- mechanical ventilation
- respiratory syndrome coronavirus
- newly diagnosed
- electronic health record
- acute care
- adverse drug
- intensive care unit
- ejection fraction
- emergency medical
- prognostic factors
- long term care
- big data
- patient reported outcomes